Biogen Shares Fall ~1.3% Amid Report Intellectual Property Right Patent Trial Against Co.'s '514 Tecfidera By Sawai Has Been Instituted By Patent Trial, Appeal Board As Claims Have Been Determined To Be Likely Invalid
Benzinga Newsdesk